OakChart

Anteris Technologies Global Corp

AVRHealthcare·Medical Devices·USA·Small·NASD·Nov 11 • 2:49 PM ET

6.18+0.29 (4.84%)
2026-11-11 20:50 CET
Market cap
574.24 USD m
Revenue, TTM
2.33 USD m
Net income, TTM
-108.15 USD m
Free cash flow, TTM
-93.48 USD m
EPS diluted, TTM
-1.60
P/E
-
Compare

Price

AVR against its 20, 50 and 200-day averages
2050200beatmiss
6.008.0010.002.3M4.7MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26AVRclose 6.1820-day 6.0150-day 7.08200-day 7.396.1852w high

44.1% under the 52-week high of 11.06 on 6 Jul 2026. 52-week low 3.30 on 21 Nov 2025. Last 15 sessions, 25.3% high to low

Profile

AVR
52-week range, 37% of the way up
3.3011.06

Anteris Technologies Global Corp. is a structural heart company, which engages in the development and commercialization of medical devices for heart diseases. It operates through the following geographical segments: United States, Germany, Australia, Switzerland, and Sweden. The company was founded in 1999 and is headquartered in Eagan, MN.

IndexRUT
Employees174
IPODec 13, 2024
Beta2.05
ATR, 14d0.39
Rel volume0.49
Short float11.12%
Insider own16.60%
Inst own74.11%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap602.03M
Enterprise Value385.67M
Income-108.15M
Sales2.33M
Book/sh2.33
Cash/sh2.39
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees174
IPODec 13, 2024

Ratios

P/E-
Forward P/E-
PEG-
P/S258.38
P/B2.65
P/C2.59
P/FCF-
EV/EBITDA-
EV/Sales165.52
Quick Ratio12.45
Current Ratio12.45
Debt/Eq0.07
LT Debt/Eq0.07
Option/ShortYes / Yes

Earnings

EPS (ttm)-1.60
EPS next Y-1.21
EPS next Q-0.31
EPS this Y53.30%
EPS next Y-1.47%
EPS next 5Y27.56%
EPS past 3/5Y-44.21% -
Sales past 3/5Y-15.77% -
EPS Y/Y TTM16.73%
Sales Y/Y TTM9.02%
EPS Q/Q55.38%
Sales Q/Q20.98%
EarningsNov 10 AMC
EPS/Sales Surpr.10.08% -81.13%

Ownership

Insider Own16.60%
Insider Trans-8.18%
Inst Own74.11%
Inst Trans-5.17%
ROA-76.82%
ROE-93.85%
ROIC-44.63%
Gross Margin-2.10%
Oper. Margin-4880.36%
Profit Margin-4637.48%
SMA202.79%
SMA50-12.82%
SMA200-16.40%
Trades-

Technical

Shs Outstand97.49M
Shs Float81.31M
Short Float11.12%
Short Ratio8.10
Short Interest9.05M
52W High11.06 -44.14%
52W Low3.30 87.12%
Volatility7.68% 6.57%
ATR (14)0.39
RSI (14)47.46
Beta2.05
Rel Volume0.49
Avg Volume1.12M
Volume451,396

Performance

Perf Week0.90%
Perf Month-4.26%
Perf Quarter-30.85%
Perf Half Y-5.44%
Perf YTD23.75%
Perf Year63.36%
Perf 3Y-
Perf 5Y-
Perf 10Y-
Recom1.83
Target Price12.81
Prev Close5.89
Price6.18
Change %4.84%

Analyst ratings

latest 7 of 7
DateActionAnalystRating changeTargetImplied
Oct 07, 2026InitiatedBBarclaysEqual Weight$10+61.9%
Mar 12, 2026ResumedCCantor FitzgeraldOverweight$15+142.9%
Mar 11, 2026InitiatedWWells FargoOverweight$16+159.1%
Jan 08, 2025InitiatedLLake StreetBuy$20+223.9%
Jan 07, 2025InitiatedTTD CowenBuy$15+142.9%
Jan 07, 2025InitiatedCCantor FitzgeraldOverweight$9+45.7%
Jan 07, 2025InitiatedBBarclaysOverweight$22+256.3%

Peers

Mkt cap
TickerCompanyMkt cap
EWEdwards Lifesciences Corp60.67B
MDTMedtronic Plc129.61B
AORTArtivion Inc989.04M
ABTAbbott Laboratories190.59B
BSXBoston Scientific Corp65.91B
LIVNLivaNova PLC5.02B
TMDXTransmedics Group Inc3.23B
ATRCAtricure Inc2.86B
CVRXCVRx Inc20.60M
IRTCiRhythm Holdings Inc2.94B

Insider trading

latest 14 of 22
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
L1 Capital Pty Ltd10% OwnerOct 06 '26Buy7.18272,6951,957,9506,358,271Oct 08 07:12 PM
L1 Capital Pty Ltd10% OwnerOct 05 '26Buy7.51648,4554,869,89712,778,380Oct 06 06:18 AM
L1 Capital Pty Ltd10% OwnerOct 02 '26Buy7.78236,3541,838,83412,129,925Oct 06 06:18 AM
L1 Capital Pty Ltd10% OwnerOct 01 '26Buy7.60322,9402,454,3445,200,767Oct 01 08:09 PM
L1 Capital Pty Ltd10% OwnerSep 30 '26Buy7.7274,286573,4884,877,827Oct 01 08:09 PM
L1 Capital Pty Ltd10% OwnerAug 28 '26Sale8.837,80068,8744,803,541Sep 01 06:24 AM
St Denis DavidChief Operating OfficerAug 19 '26Option Exercise5.6560,000339,000161,082Aug 20 07:49 PM
L1 Capital Pty Ltd10% OwnerAug 11 '26Sale9.30375,8153,495,0804,811,341Aug 12 06:13 AM
L1 Capital Pty Ltd10% OwnerAug 10 '26Sale9.10251,8442,291,7805,187,156Aug 12 06:13 AM
L1 Capital Pty Ltd10% OwnerAug 06 '26Sale8.10174,7211,415,2405,439,000Aug 10 07:24 AM
L1 Capital Pty Ltd10% OwnerAug 04 '26Sale8.30480,6083,989,0465,628,302Aug 06 06:48 AM
L1 Capital Pty Ltd10% OwnerAug 05 '26Sale8.2314,581120,0025,613,721Aug 06 06:48 AM
L1 Capital Pty Ltd10% OwnerAug 03 '26Sale8.10475,6933,853,1136,108,910Aug 04 06:23 AM
L1 Capital Pty Ltd10% OwnerJul 31 '26Sale8.1548,711396,9956,584,603Aug 04 06:23 AM

Held by

AUM
TickerCompanyAUM
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
XHEState Street SPDR S&P Health Care Equipment ETFAUM: 160.14M
IWCiShares Micro-Cap ETFAUM: 1.22B
VFMOVanguard U.S. Momentum Factor ETFAUM: 1.82B
FESMFidelity Enhanced Small Cap Core ETFAUM: 6.82B
ITOTiShares Core S&P Total U.S. Stock Market ETFAUM: 95.28B

News

latest 14 of 116

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-10-0.280-0.311-0.2480.522.755
2026Q22026-08-10-0.300-0.207-0.2991.011.503
2026Q12026-05-12-0.280-0.271-0.2770.490.773
2025Q42026-02-26-0.740-0.503-0.7490.300.203
2025Q32025-11-11-0.620-0.542-0.6170.430.403
2025Q22025-08-11-0.580-0.545-0.5780.620.402
2025Q12025-05-12-0.610-0.491-0.6070.560.474
2024Q42025-02-26-0.610-0.565-0.5390.600.734
2024Q32024-11-27-1.069--0.6080.80--
2026Q4---0.312--2.955
2027Q1---0.273--2.604
2027Q2---0.294--2.604
2027Q3---0.295--2.604
2027Q4---0.285--2.604
2028Q1---0.207--2.002
2028Q2---0.123--2.502

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2024FY-3.680-2.974-2.1232.702.85
2025FY-2.550-2.263-2.4221.911.80
2026FY--1.191--6.34
2027FY--1.208--8.40
2028FY--0.970--13.42
2029FY--0.678--103
2030FY--0.560--297.35

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-114002.950.006.40
2026Q4S2026-11-104002.950.006.40
2026Q4S2026-10-314002.950.006.40
2026Q4S2026-10-274012.950.006.40
2026Q4S2026-08-174022.950.006.40
2026Q4S2026-08-134013.981.906.40
2026Q4S2026-08-124004.151.906.40
2026Q4S2026-08-113004.904.106.40
2026Q4S2026-08-023004.904.106.40
2026Q4S2026-07-273014.904.106.40
2026Q4S2026-05-263114.904.106.40
2026Q4S2026-05-193124.904.106.40
2026Q4S2026-05-133114.974.106.60
2026Q4S2026-05-013014.833.806.60

Estimate history

EPS, annual-0.85-1.281-2.123-2.551-1.6004
Period2022202320242025TTM
EPS, quarterly-0.608-0.539-0.607-0.578-0.617-0.749-0.277-0.299-0.275
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual3.2012.7352.7031.9132.33
Period2022202320242025TTM
Sales, quarterly0.7690.5360.5560.6180.4290.310.4941.0090.519
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual35.9435.9435.9441.5897.493
Period2022202320242025MRQ
Shares, quarterly35.9435.9436.06236.06236.06241.5897.23297.41197.493
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY
Total Revenue2.331.912.702.733.20
Cost of Goods Sold Incl. D&A2.382.232.943.023.68
Gross Profit-0.05-0.32-0.24-0.28-0.48
Selling, General and Administrative Excl. Other113.7693.5878.1347.0932.26
Research and Development81.6769.1251.4530.8917.59
Other Operating Expense0.000.000.000.000.00
Operating Income-113.81-93.89-78.37-47.37-32.73
Interest Expense0.180.070.510.070.65
Unusual Expense-0.04-0.020.960.120.26
Net Income Before Taxes-107.30-94.22-75.97-46.76-30.56
Income Taxes0.220.000.000.000.00
Consolidated Net Income-107.52-94.22-75.97-46.76-30.56
Net Income From Continuing Operations-108.15-94.14-76.29-46.02-30.56
Net Income-108.15-94.14-76.29-46.02-30.56
EPS (Recurring)-1.11-2.55-2.10-1.28-0.85
EPS (Basic, Before Extraordinaries)-1.60-2.55-2.12-1.28-0.85
EPS (Diluted)-1.60-2.55-2.12-1.28-0.85
EBITDA-111.99-92.23-76.86-46.22-31.96
Non-Operating Income (Expense)6.65-0.283.880.803.07
Other After Tax Adjustments0.000.000.000.000.00
Stock Option Compensation Expense8.867.845.996.512.94
Price To Sales Ratio324.7396.2874.19--
Gross Margin-2.10-16.57-8.92-10.27-14.86
Operating Margin-4,880.36-4,908.21-2,899.45-1,732.25-1,022.63
Net Margin-4,637.48-4,921.28-2,822.46-1,682.81-954.91
Shares Outstanding97.4941.5835.9435.9435.94
Market Capitalization574.24574.24200.54200.54-

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue0.521.010.490.310.430.620.560.54
Cost of Goods Sold Incl. D&A0.620.700.540.510.540.430.410.61
Gross Profit-0.100.31-0.05-0.20-0.110.190.15-0.08
Selling, General and Administrative Excl. Other29.7431.3023.9628.7622.1521.2121.9321.44
Research and Development21.3323.3717.4619.5116.8116.3416.4613.32
Other Operating Expense0.000.000.000.000.00-0.140.000.00
Operating Income-29.84-31.00-24.01-28.96-22.27-20.88-21.78-21.52
Interest Expense0.020.130.030.010.010.020.030.47
Unusual Expense0.00-0.040.00-0.00-0.01-0.01-0.000.91
Net Income Before Taxes-27.10-28.78-22.41-29.02-22.21-21.06-21.93-19.20
Income Taxes-0.270.000.490.000.000.000.000.00
Consolidated Net Income-26.83-28.78-22.90-29.02-22.21-21.06-21.93-19.20
Net Income From Continuing Operations-26.83-29.09-23.02-29.20-22.24-20.83-21.86-19.38
Net Income-26.83-29.09-23.02-29.20-22.24-20.83-21.86-19.38
EPS (Recurring)-0.28-0.30-0.28-0.75-0.62-0.58-0.61-0.52
EPS (Basic, Before Extraordinaries)-0.28-0.30-0.28-0.75-0.62-0.58-0.61-0.54
EPS (Diluted)-0.28-0.30-0.28-0.75-0.62-0.58-0.61-0.54
EBITDA-29.34-30.53-23.58-28.54-21.85-20.47-21.38-21.11
Non-Operating Income (Expense)2.762.321.63-0.050.06-0.16-0.133.70
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.113.141.523.091.601.581.561.02
Price To Sales Ratio324.73427.65248.89101.7175.8655.1352.5974.19
Gross Margin-19.8530.43-9.92-65.81-25.8730.9626.53-14.16
Operating Margin-5,749.71-3,072.05-4,859.72-9,343.55-5,189.98-3,379.29-3,917.27-4,013.86
Net Margin-5,168.79-2,883.45-4,660.73-9,420.00-5,185.08-3,371.20-3,932.37-3,614.02
Shares Outstanding97.4997.4197.2341.5836.0636.0636.0635.94
Market Capitalization574.24958.82539.64205.58162.28136.68131.13200.54

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY
Cash & Short Term Investments12.5870.4621.099.35
Short Term Receivables0.312.251.130.56
Inventories0.730.510.440.36
Other Current Assets0.641.431.561.97
Total Current Assets14.2674.6524.2212.24
Net Property, Plant & Equipment7.265.865.483.14
Total Investments and Advances0.000.000.000.00
Intangible Assets0.070.190.410.61
Deferred Tax Assets1.41---
Other Assets1.410.000.420.00
Total Assets24.4080.7030.5315.99
Short Term Debt Incl. Current Port. of LT Debt0.580.750.670.51
Accounts Payable11.095.893.141.73
Other Current Liabilities9.709.925.653.81
Total Current Liabilities21.3716.569.466.05
Long Term Debt1.700.651.020.44
Provision for Risks Charges0.140.761.150.47
Deferred Tax Liabilities1.41---
Other Liabilities0.040.050.000.00
Total Liabilities24.6618.0211.636.95
Non-Equity Reserves0.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.00
Common Equity-0.0962.7619.309.03
Total Shareholders Equity-0.0962.7619.309.03
Accumulated Minority Interest-0.16-0.08-0.400.00
Total Equity-0.2562.6818.909.03
Total Liabilities & Stockholders Equity24.4080.7030.5315.99
Book Value Per Share-0.001.750.540.25
Tangible Book Value Per Share-0.001.740.530.23
Full-Time Employees174136--
Price to Book Ratio2.2863.6863.68-
Return on Assets-179.15-137.18-197.89-
Return on Equity-300.45-185.94-324.85-
Return on Invested Capital-5,858.37-120.32-226.47-322.64
Quick Ratio0.634.482.511.97
Current Ratio0.674.512.562.02

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY
Net Income-107.52-94.22-75.97-46.76-30.56
Depreciation1.821.661.511.160.77
Other Funds (Non Cash)9.418.506.536.992.12
Funds from Operations-96.30-84.07-67.93-38.62-27.67
Extraordinary Item0.000.000.000.000.00
Changes in Working Capital5.406.266.693.99-1.75
Cash from Operating Activities-90.90-77.80-61.24-34.63-29.42
Capital Expenditures-2.62-1.95-2.28-2.39-1.67
Net Assets From Acquisitions0.000.000.00-0.210.00
Sale of Fixed Assets and Businesses0.000.000.000.030.00
Purchase or Sale of Investments0.000.000.000.000.00
Purchase of Investments0.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.00
Other Uses0.000.000.000.000.00
Other Sources0.001.360.000.000.67
Cash from Investing Activities-2.62-0.60-2.28-2.58-0.99
Cash Dividends Paid0.000.000.000.000.00
Change in Capital Stock323.4023.02115.7350.1524.25
Repurchase of Common Pref Stock0.000.000.000.000.00
Sale of Common Pref Stock323.4023.02115.7350.1524.25
Proceedsfrom Stock Options323.4023.02115.7350.1524.25
Issuance or Reduction of Debt, Net-1.27-1.24-2.70-0.81-0.98
Change in Long Term Debt-1.27-1.24-2.70-0.81-0.98
Issuance of Long Term Debt0.000.004.490.000.00
Reduction of Long Term Debt-1.27-1.24-7.20-0.81-0.98
Net Financing Active Other Cash Flow-1.38-1.23-0.190.000.00
Other Financing Activities Uses-1.38-1.23-0.190.000.00
Cash from Financing Activities320.7520.55112.8349.3423.27
Exchange Rate Effect-0.01-0.040.06-0.391.04
Net Change in Cash227.22-57.8849.3711.74-6.10
Free Cash Flow-93.48-79.76-63.51-37.02-30.99
Preferred Dividends (Cash Flow)-0.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments232.76257.38283.2112.589.1228.44
Short Term Receivables0.220.550.230.310.230.69
Inventories0.000.010.120.730.440.45
Other Current Assets4.612.713.110.641.442.64
Total Current Assets237.58260.65286.6714.2611.2232.21
Net Property, Plant & Equipment21.218.257.957.267.277.05
Total Investments and Advances3.583.510.000.000.000.00
Intangible Assets0.090.100.100.070.070.10
Deferred Tax Assets---1.41--
Other Assets0.000.000.001.410.510.51
Total Assets262.46272.51294.7224.4019.0739.88
Short Term Debt Incl. Current Port. of LT Debt0.591.031.310.580.721.07
Accounts Payable5.625.103.7911.094.285.40
Other Current Liabilities12.8712.238.599.708.446.87
Total Current Liabilities19.0918.3613.6921.3713.4313.34
Long Term Debt15.522.292.421.701.631.74
Provision for Risks Charges0.000.000.000.140.610.72
Deferred Tax Liabilities---1.41--
Other Liabilities0.800.180.190.040.040.05
Total Liabilities35.4120.8416.3124.6615.7115.85
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity226.77251.39278.44-0.093.7024.41
Total Shareholders Equity226.77251.39278.44-0.093.7024.41
Accumulated Minority Interest0.280.28-0.03-0.16-0.34-0.37
Total Equity227.05251.67278.41-0.253.3624.03
Total Liabilities & Stockholders Equity262.46272.51294.7224.4019.0739.88
Book Value Per Share2.332.582.86-0.000.100.68
Tangible Book Value Per Share2.332.582.86-0.000.100.67
Full-Time Employees---174--
Price to Book Ratio2.283.44-2,477.6848.666.653.16
Return on Assets-76.82-66.31-53.92-179.15-419.74-296.17
Return on Equity-93.85-75.10-59.25-300.45-2,462.70-615.48
Return on Invested Capital-11.07-11.47-8.20-1,817.17-417.41-79.68
Quick Ratio12.4514.2020.930.630.802.38
Current Ratio12.4514.2020.930.670.842.41

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-26.83-28.78-22.90-29.02-22.21-21.06
Depreciation0.500.470.430.420.420.42
Other Funds (Non Cash)2.132.221.903.161.571.86
Funds from Operations-24.20-26.09-20.57-25.44-20.22-18.78
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital1.315.29-8.116.911.97-0.75
Cash from Operating Activities-22.90-20.80-28.68-18.53-18.25-19.54
Capital Expenditures-1.40-0.65-0.18-0.40-0.77-0.54
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-1.40-0.65-0.18-0.40-0.77-0.54
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.14-0.41300.0723.600.00-0.03
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.14-0.41300.0723.600.00-0.03
Proceedsfrom Stock Options0.14-0.41300.0723.600.00-0.03
Issuance or Reduction of Debt, Net-0.30-0.32-0.56-0.09-0.29-0.31
Change in Long Term Debt-0.30-0.32-0.56-0.09-0.29-0.31
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt-0.30-0.32-0.56-0.09-0.29-0.31
Net Financing Active Other Cash Flow-0.10-0.150.00-1.130.00-0.10
Other Financing Activities Uses-0.10-0.150.00-1.130.00-0.10
Cash from Financing Activities-0.26-0.88299.5122.38-0.29-0.44
Exchange Rate Effect-0.010.01-0.01-0.00-0.00-0.00
Net Change in Cash-24.56-22.32270.633.46-19.32-20.52
Free Cash Flow-24.29-21.45-28.82-18.92-19.02-20.07

Revenue breakdown

Orthopedic, Prosthetic & Surgical Appliances & Supplies2024: 2.70M 2025: 1.91M
Australia2024: 21.00K 2025: 33.00K
Germany2024: 900.00K 2025: 272.00K
United States2024: 1.78M 2025: 1.61M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3011.12%9.0M81.3M1.05M
2026-10-159.76%7.9M81.3M960.63K
2026-09-308.21%6.7M81.3M899.01K
2026-09-157.90%6.4M81.3M1.03M
2026-08-318.58%7.0M81.3M1.14M
2026-08-148.53%6.9M81.3M1.27M
2026-07-318.79%7.1M81.2M1.24M
2026-07-159.94%8.1M81.2M1.19M
2026-06-307.57%6.2M81.2M1.11M
2026-06-156.99%5.7M81.2M1.04M
2026-05-296.66%5.4M81.3M993.61K
2026-05-155.15%4.2M81.3M871.91K
2026-04-304.61%3.7M81.2M907.42K
2026-04-156.96%4.1M59.3M1.38M
2026-03-317.05%4.2M59.3M1.28M
2026-03-134.06%2.4M59.3M1.08M
2026-02-273.69%2.2M59.3M930.64K
2026-02-139.19%2.3M25.1M855.42K
2026-01-308.91%2.2M25.1M719.87K
2026-01-153.93%1.6M40.8M237.97K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.502.804.407.358.9241.000.000.955-0.0220.001
call5.000.701.551.052.47535.000.000.862-0.0170.002
call7.500.000.050.021.3863,5170.000.216-0.0220.003
call10.000.000.800.031.9064370.000.069-0.0140.001
call12.500.000.300.452.53987.000.000.056-0.0150.001
call15.000.000.600.253.0101560.000.049-0.0160.001
call17.500.000.600.453.4311.000.000.045-0.0170.001
call20.000.000.600.353.7321010.000.042-0.0180.001
put2.500.000.400.034.2091.000.00-0.046-0.0220.001
put5.000.050.100.151.3191,6840.00-0.192-0.0180.003
put7.501.301.651.641.8928410.00-0.885-0.0100.002
put10.003.504.303.243.3460.000.00-0.931-0.0130.001
put12.504.607.800.007.2270.000.00-0.944-0.0140.001
put15.007.1010.800.009.1990.000.00-0.951-0.0150.001
put17.509.6013.300.009.7390.000.00-0.955-0.0150.001
put20.0012.1015.800.0010.2020.000.00-0.958-0.0160.001

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-09ARSAnnual report to security holders. 2025-12-31SEC
2026-11-09DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-12-02SEC
2026-11-0910-Q/A2026-06-30SEC
2026-11-0910-Q/A2026-03-31SEC
2026-11-0910-K/A2025-12-31SEC
2026-11-05SCHEDULE 13G/ASEC
2026-11-043Initial statement of beneficial ownership of securities2026-10-26SEC
2026-10-28PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-12-02SEC
2026-10-084Statement of changes in beneficial ownership of securities2026-10-06SEC
2026-10-064Statement of changes in beneficial ownership of securities2026-10-02SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-09-24424B3SEC
2026-09-238-KCurrent report2026-09-23SEC
2026-09-21424B3SEC
2026-09-178-KCurrent report2026-09-12SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-11SEC
2026-09-163Initial statement of beneficial ownership of securities2026-09-11SEC
2026-09-09424B3SEC
2026-09-088-KCurrent report2026-09-04SEC
2026-09-03SCHEDULE 13G/ASEC
2026-09-014Statement of changes in beneficial ownership of securities2026-08-28SEC
2026-08-204Statement of changes in beneficial ownership of securities2026-08-19SEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-12424B3SEC
2026-08-128-KCurrent report2026-08-11SEC
2026-08-1110-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-104Statement of changes in beneficial ownership of securities2026-08-06SEC
2026-08-07SCHEDULE 13G/ASEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-1011.12M400
2026-09573.49K100
2026-080015.23M7
2026-070010.01M6
2026-06102.23K100
2026-050000
2026-040000
2026-030000
2026-020000
2026-0128.75M100
2025-120000
2025-110000

Institutional holders

Manager% owned
FMR LLC8.70%
L1 Capital Pty Ltd8.00%
Nantahala Capital Management, LLC6.95%
BlackRock, Inc.5.93%
Sio Capital Management, LLC5.70%
PERCEPTIVE ADVISORS LLC3.52%
ADAR1 Capital Management, LLC3.23%
RA CAPITAL MANAGEMENT, L.P.3.08%
BVF INC/IL3.08%
Ensign Peak Advisors, Inc2.46%

Funds

Fund% owned
iShares Russell 2000 ETF2.20%
Fidelity Series International Small Cap Fund2.04%
Fidelity Pacific Basin Fund1.84%
Fidelity International Small Cap Opportunities Fund1.40%
Fidelity Small Cap Index Fund0.92%
VANGUARD EXTENDED MARKET INDEX FUND0.89%
iShares Russell 2000 Value ETF0.78%
VANGUARD RUSSELL 2000 INDEX FUND0.48%
Strategic Advisers Fidelity U.S. Total Stock Fund0.42%
Fidelity Extended Market Index Fund0.39%

OakChart. AVR. Cached 15 minutes.